LBTSF
Price
$13.36
Change
+$4.35 (+48.28%)
Updated
Jun 26 closing price
Capitalization
2.01B
MEDXF
Price
$2.27
Change
-$0.03 (-1.30%)
Updated
Jul 3 closing price
Capitalization
31.92M
30 days until earnings call
Interact to see
Advertisement

LBTSF vs MEDXF

Header iconLBTSF vs MEDXF Comparison
Open Charts LBTSF vs MEDXFBanner chart's image
Almirall SA
Price$13.36
Change+$4.35 (+48.28%)
Volume$332
Capitalization2.01B
Medexus Pharmaceuticals
Price$2.27
Change-$0.03 (-1.30%)
Volume$6.76K
Capitalization31.92M
LBTSF vs MEDXF Comparison Chart in %
Loading...
LBTSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEDXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LBTSF vs. MEDXF commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LBTSF is a Hold and MEDXF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (LBTSF: $13.36 vs. MEDXF: $2.27)
Brand notoriety: LBTSF and MEDXF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: LBTSF: 237% vs. MEDXF: 82%
Market capitalization -- LBTSF: $2.01B vs. MEDXF: $31.92M
LBTSF [@Pharmaceuticals: Other] is valued at $2.01B. MEDXF’s [@Pharmaceuticals: Other] market capitalization is $31.92M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LBTSF’s FA Score shows that 1 FA rating(s) are green whileMEDXF’s FA Score has 1 green FA rating(s).

  • LBTSF’s FA Score: 1 green, 4 red.
  • MEDXF’s FA Score: 1 green, 4 red.
According to our system of comparison, MEDXF is a better buy in the long-term than LBTSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LBTSF’s TA Score shows that 0 TA indicator(s) are bullish while MEDXF’s TA Score has 3 bullish TA indicator(s).

  • LBTSF’s TA Score: 0 bullish, 2 bearish.
  • MEDXF’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, LBTSF is a better buy in the short-term than MEDXF.

Price Growth

LBTSF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while MEDXF (@Pharmaceuticals: Other) price change was -2.11% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

MEDXF is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LBTSF($2.01B) has a higher market cap than MEDXF($31.9M). LBTSF has higher P/E ratio than MEDXF: LBTSF (49.75) vs MEDXF (26.67). LBTSF YTD gains are higher at: 45.645 vs. MEDXF (-5.963). LBTSF has higher annual earnings (EBITDA): 150M vs. MEDXF (14.6M). LBTSF has more cash in the bank: 447M vs. MEDXF (13.1M). MEDXF has less debt than LBTSF: MEDXF (70.1M) vs LBTSF (398M). LBTSF has higher revenues than MEDXF: LBTSF (893M) vs MEDXF (108M).
LBTSFMEDXFLBTSF / MEDXF
Capitalization2.01B31.9M6,310%
EBITDA150M14.6M1,027%
Gain YTD45.645-5.963-766%
P/E Ratio49.7526.67187%
Revenue893M108M827%
Total Cash447M13.1M3,412%
Total Debt398M70.1M568%
FUNDAMENTALS RATINGS
LBTSF vs MEDXF: Fundamental Ratings
LBTSF
MEDXF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
66
Overvalued
PROFIT vs RISK RATING
1..100
7692
SMR RATING
1..100
8864
PRICE GROWTH RATING
1..100
3641
P/E GROWTH RATING
1..100
932
SEASONALITY SCORE
1..100
3550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LBTSF's Valuation (33) in the null industry is somewhat better than the same rating for MEDXF (66). This means that LBTSF’s stock grew somewhat faster than MEDXF’s over the last 12 months.

LBTSF's Profit vs Risk Rating (76) in the null industry is in the same range as MEDXF (92). This means that LBTSF’s stock grew similarly to MEDXF’s over the last 12 months.

MEDXF's SMR Rating (64) in the null industry is in the same range as LBTSF (88). This means that MEDXF’s stock grew similarly to LBTSF’s over the last 12 months.

LBTSF's Price Growth Rating (36) in the null industry is in the same range as MEDXF (41). This means that LBTSF’s stock grew similarly to MEDXF’s over the last 12 months.

MEDXF's P/E Growth Rating (2) in the null industry is significantly better than the same rating for LBTSF (93). This means that MEDXF’s stock grew significantly faster than LBTSF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LBTSFMEDXF
RSI
ODDS (%)
Bearish Trend 5 days ago
17%
Bearish Trend 5 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
15%
Bullish Trend 5 days ago
83%
Momentum
ODDS (%)
N/A
Bearish Trend 5 days ago
88%
MACD
ODDS (%)
N/A
Bearish Trend 5 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
13%
Bearish Trend 5 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
13%
Bullish Trend 5 days ago
83%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
82%
BollingerBands
ODDS (%)
N/A
Bearish Trend 5 days ago
79%
Aroon
ODDS (%)
N/A
Bullish Trend 5 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
LBTSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEDXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FURCF9.33N/A
N/A
FORVIA SE
IPZYF0.68N/A
N/A
IP Group PLC
CTRNF0.12N/A
N/A
CHAR TECHNOLOGIES LTD
LGRDY26.42-0.09
-0.34%
LeGrand SA
NICLF0.11-0.04
-26.01%
Class 1 Nickel and Technologies Limited

LBTSF and

Correlation & Price change

A.I.dvisor tells us that LBTSF and IPSEY have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LBTSF and IPSEY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LBTSF
1D Price
Change %
LBTSF100%
N/A
IPSEY - LBTSF
16%
Poorly correlated
N/A
MEDXF - LBTSF
10%
Poorly correlated
-1.27%
LVRLF - LBTSF
3%
Poorly correlated
-8.29%
MKGAF - LBTSF
3%
Poorly correlated
+0.12%
KSPHF - LBTSF
0%
Poorly correlated
N/A
More

MEDXF and

Correlation & Price change

A.I.dvisor tells us that MEDXF and LBTSF have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MEDXF and LBTSF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEDXF
1D Price
Change %
MEDXF100%
-1.27%
LBTSF - MEDXF
10%
Poorly correlated
N/A
MRMD - MEDXF
9%
Poorly correlated
+0.70%
MKGAF - MEDXF
7%
Poorly correlated
+0.12%
KHTRF - MEDXF
5%
Poorly correlated
+4.50%
MCUJF - MEDXF
4%
Poorly correlated
N/A
More